ZFIN ID: ZDB-FIG-171018-25
Somatic inactivation of cdkn2a/b gene by the injection of TALENs mRNA leads to MPNSTs in F0 founder zebrafish. (A) The targeted regions of two different TALENs (cdkn2a/b TALENs-1 and cdkn2a/b TALENs-2) are located in exon 1 of cdkn2a/b gene. The binding sequences of TALENs for cdkn2a/b gene are also shown. (B) By the injection of cdkn2a/b TALENs-1 mRNA, 7 different germline mutated alleles of cdkn2a/b gene were recovered at F1 generation. And 9 different alleles were also recovered at F1 generation after injection of cdkn2a/b TALENs-2 mRNA. (C) The large mass of tumor was observed in adjacent to eyes of the cdkn2a/b TALENs mRNA injected tp53 mutant zebrafish at 5.5 month post fertilization. (D–F) Histological image of cross sections of tumor tissue was visualized with Hematoxylin-Eosin staining. (D) High magnification image of tumor tissue shows the herringbone pattern that is a typical feature of malignant peripheral nerve sheath tumor. (F) There is no evident abnormality in the neuroepithelial layer of retina adjacent to tumor tissue. (G) Kaplan-Meier survival representation of wild type (AB), tp53 mutant, and cdkn2a/b TALENs mRNA injected AB or tp53 mutant zebrafish. The cdkn2a/b TALENs mRNA injected tp53 mutant zebrafish had only started to exhibit death with tumor bearing as early as about 5 months. Other adult zebrafish such as tp53 mutant and cdkn2a/b TALENs mRNA injected AB zebrafish did not show early death with tumor bearing. All data was acquired from two independent experiments. Scale bars: 2 mm (E) and 100 μm (D and F).
Gene Expression Details
No data available
Antibody Labeling Details
No data available
ZFIN wishes to thank the journal Oncotarget for permission to reproduce figures from this article.
Please note that this material may be protected by copyright.
Full text @ Oncotarget